Cargando…

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy

Immune checkpoint blockade (ICB) therapy is a powerful option for cancer treatment. Despite demonstrable progress, most patients fail to respond or achieve durable responses due to primary or acquired ICB resistance. Recently, tumor epithelial-to-mesenchymal plasticity (EMP) was identified as a crit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Yuanzhuo, Zhang, Zhengkui, ten Dijke, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066239/ https://www.ncbi.nlm.nih.gov/pubmed/36823234 http://dx.doi.org/10.1038/s41423-023-00980-8

Ejemplares similares

Genome-wide CRISPR screens define determinants of epithelial-mesenchymal transition mediated immune evasion by pancreatic cancer cells
por: Gu, Yuanzhuo, et al.
Publicado: (2023)

Epithelial-to-Mesenchymal Plasticity Harnesses Endocytic Circuitries
por: Corallino, Salvatore, et al.
Publicado: (2015)

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)

Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
por: Zhang, Jing, et al.
Publicado: (2020)

Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity
por: Sundqvist, Anders, et al.
Publicado: (2012)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
por: Hua, Wan, et al.
Publicado: (2019)

Harnessing the power of traditional Chinese medicine monomers and compound prescriptions to boost cancer immunotherapy
por: Miao, Keyan, et al.
Publicado: (2023)

Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients
por: Gkountakos, Anastasios, et al.
Publicado: (2021)

Harnessing the Microbiome to Enhance Cancer Immunotherapy
por: Nelson, Michelle H., et al.
Publicado: (2015)

Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
por: Hao, Yang, et al.
Publicado: (2023)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Regulation of endothelial cell plasticity by TGF-β
por: van Meeteren, Laurens A., et al.
Publicado: (2011)

Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)

Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition
por: Hua, Wan, et al.
Publicado: (2021)

Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
por: Hannon, Gary, et al.
Publicado: (2023)

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
por: Sulsenti, Roberta, et al.
Publicado: (2023)

Harnessing tumor-associated macrophages as aids for cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2019)

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

Epithelial–mesenchymal plasticity in carcinoma metastasis
por: Tsai, Jeff H., et al.
Publicado: (2013)

Metabolic Plasticity and Epithelial-Mesenchymal Transition
por: Thomson, Timothy M., et al.
Publicado: (2019)

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
por: Drakes, Maureen L, et al.
Publicado: (2014)

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer
por: Klymenko, Yuliya, et al.
Publicado: (2017)

Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors
por: Rajani, Karishma R., et al.
Publicado: (2015)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Harnessing immunological targets for COVID-19 immunotherapy
por: Mehata, Abhishesh Kumar, et al.
Publicado: (2021)

Epigenetic Strategies to Boost Cancer Immunotherapies
por: Barrero, Maria J.
Publicado: (2017)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Research models and mesenchymal/epithelial plasticity of osteosarcoma
por: Yu, Xiaobin, et al.
Publicado: (2021)

Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
por: Bae, Jihong, et al.
Publicado: (2022)

Revisiting epithelial‐mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness
por: Liao, Tsai‐Tsen, et al.
Publicado: (2017)

Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells
por: Zhang, Jing, et al.
Publicado: (2023)

Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
por: Amon, Lukas, et al.
Publicado: (2020)

Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
por: Mercogliano, María Florencia, et al.
Publicado: (2021)

The therapeutic potential of targeting the endothelial-to-mesenchymal transition
por: Man, Shirley, et al.
Publicado: (2018)

Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity
por: Drasin, David J, et al.
Publicado: (2011)

Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer
por: Bedi, Upasana, et al.
Publicado: (2014)

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
por: Loret, Nele, et al.
Publicado: (2019)

Regulation of Epithelial–Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer
por: Rodríguez-Alonso, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olu25aahl981ro04n93flsvj5o